Park Avenue Securities LLC bought a new position in shares of Archrock, Inc. (NYSE:AROC – Free Report) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 27,447 shares of the energy company’s stock, valued at approximately $683,000.
Other hedge funds have also modified their holdings of the company. GAMMA Investing LLC boosted its stake in Archrock by 36.8% in the 4th quarter. GAMMA Investing LLC now owns 7,181 shares of the energy company’s stock worth $179,000 after purchasing an additional 1,930 shares during the period. JPMorgan Chase & Co. lifted its holdings in shares of Archrock by 94.5% in the third quarter. JPMorgan Chase & Co. now owns 422,383 shares of the energy company’s stock valued at $8,549,000 after purchasing an additional 205,241 shares in the last quarter. Principal Financial Group Inc. boosted its position in shares of Archrock by 24.4% in the third quarter. Principal Financial Group Inc. now owns 853,295 shares of the energy company’s stock worth $17,271,000 after buying an additional 167,510 shares during the period. B. Riley Wealth Advisors Inc. grew its holdings in shares of Archrock by 0.9% during the third quarter. B. Riley Wealth Advisors Inc. now owns 50,654 shares of the energy company’s stock valued at $1,025,000 after buying an additional 427 shares in the last quarter. Finally, Franklin Resources Inc. raised its position in Archrock by 5.9% during the third quarter. Franklin Resources Inc. now owns 94,756 shares of the energy company’s stock valued at $2,020,000 after buying an additional 5,295 shares during the period. 95.45% of the stock is owned by hedge funds and other institutional investors.
Archrock Stock Down 2.0 %
Shares of AROC stock opened at $29.75 on Thursday. The stock has a market cap of $5.21 billion, a P/E ratio of 32.69, a price-to-earnings-growth ratio of 1.80 and a beta of 1.58. The company has a debt-to-equity ratio of 1.73, a current ratio of 1.26 and a quick ratio of 0.82. The stock has a fifty day moving average price of $25.81 and a 200 day moving average price of $22.41. Archrock, Inc. has a one year low of $15.60 and a one year high of $30.44.
Analyst Upgrades and Downgrades
AROC has been the subject of a number of research reports. JPMorgan Chase & Co. lifted their target price on shares of Archrock from $25.00 to $27.00 and gave the company an “overweight” rating in a research note on Friday, November 29th. Royal Bank of Canada boosted their target price on Archrock from $26.00 to $27.00 and gave the company an “outperform” rating in a research note on Thursday, November 14th. Citigroup initiated coverage on Archrock in a research note on Friday, September 27th. They set a “buy” rating and a $24.00 price target for the company. Evercore ISI initiated coverage on Archrock in a research note on Wednesday, September 25th. They issued an “outperform” rating and a $24.00 price target for the company. Finally, Mizuho assumed coverage on Archrock in a report on Wednesday, October 2nd. They issued an “outperform” rating and a $24.00 price objective on the stock. One equities research analyst has rated the stock with a hold rating and six have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $25.17.
Get Our Latest Research Report on Archrock
About Archrock
Archrock, Inc, together with its subsidiaries, operates as an energy infrastructure company in the United States. The company operates in two segments, Contract Operations and Aftermarket Services. It engages in the designing, sourcing, owning, installing, operating, servicing, repairing, and maintaining of its owned fleet of natural gas compression equipment to provide natural gas compression services.
Featured Articles
- Five stocks we like better than Archrock
- 3 Monster Growth Stocks to Buy Now
- Oracle Announces Game-Changing News for the AI Industry
- Investing in the High PE Growth Stocks
- Netflix Adds 19 Million Subscribers, Growth Is Far From Over
- How to Capture the Benefits of Dividend Increases
- Tempus AI: A Game-Changer in AI-Powered Healthcare
Receive News & Ratings for Archrock Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Archrock and related companies with MarketBeat.com's FREE daily email newsletter.